Literature DB >> 6198083

Pulmonary toxicity of antitumor agents.

F M Muggia, A C Louie, B I Sikic.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6198083     DOI: 10.1016/0305-7372(83)90012-9

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  18 in total

1.  Mouse Models of Skin Fibrosis.

Authors:  Aleix Rius Rigau; Markus Luber; Jörg H W Distler
Journal:  Methods Mol Biol       Date:  2021

2.  Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene.

Authors:  P L Tran; J Weinbach; P Opolon; G Linares-Cruz; J P Reynes; A Grégoire; E Kremer; H Durand; M Perricaudet
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 3.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 4.  Progress toward improving animal models for idiopathic pulmonary fibrosis.

Authors:  Amber L Degryse; William E Lawson
Journal:  Am J Med Sci       Date:  2011-06       Impact factor: 2.378

5.  NMR study of the effects of some bleomycin C-termini on the structure of a DNA hairpin with the 5'-GC-3' binding site.

Authors:  Teresa E Lehmann; Sally A Murray; Azure D Ingersoll; Teresa M Reilly; Shelby E Follett; Kevin E Macartney; Mark H Harpster
Journal:  J Biol Inorg Chem       Date:  2016-11-17       Impact factor: 3.358

6.  Impact of childhood cancer on return to normal schooling.

Authors:  I J Larcombe; J Walker; A Charlton; S Meller; P Morris Jones; M G Mott
Journal:  BMJ       Date:  1990-07-21

7.  Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome--recall following different chemotherapy agents.

Authors:  Yuk Fung Hui; Francis J Giles; Jorge E Cortes
Journal:  Invest New Drugs       Date:  2002-02       Impact factor: 3.850

8.  Angiotensin-converting enzyme N-terminal inactivation alleviates bleomycin-induced lung injury.

Authors:  Ping Li; Hong D Xiao; Jianguo Xu; Frank S Ong; Mike Kwon; Jesse Roman; Anthony Gal; Kenneth E Bernstein; Sebastien Fuchs
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

9.  Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease.

Authors:  Rebecca Lee; Charles Reese; Michael Bonner; Elena Tourkina; Zoltan Hajdu; Ellen C Riemer; Richard M Silver; Richard P Visconti; Stanley Hoffman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-28       Impact factor: 5.464

Review 10.  Animal models of fibrotic lung disease.

Authors:  Bethany B Moore; William E Lawson; Tim D Oury; Thomas H Sisson; Krishnan Raghavendran; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.